Literature DB >> 27379392

Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry.

Ruixing Zhang1,2, Xiaoyu Zhuang1,2, Li Zong1,2, Shu Liu1, Zhiqiang Liu1, Fengrui Song3.   

Abstract

Although anticancer drug resistance has been linked to high expression of P-glycoprotein and the enhanced DNA repair ability, the biochemical process and the underlying mechanisms of drug resistance are not clear. In order to clarify the biochemical mechanisms of drug resistance during anticancer drug treatment, we studied the metabolomics of MCF-7/S and MCF-7/Adr cell lines, the COC1 and COC1/DDP cell lines, including the metabolic pathways of multidrug-resistant tumor cells and the changes of endogenous substances in cells. The intracellular metabolites were profiled using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). In this study, 24 biomarkers in MCF-7/Adr cells and 15 biomarkers in COC1/DDP cells that are involved in some important metabolic pathways were putatively identified. Several metabolic pathways are changed in tumor cells showing drug resistance, such as protein synthesis pathways, cysteine synthesis, the glutamine metabolic pathway, and the ammonia cycle; the first of these are involved in the synthesis of some important proteins including membrane proteins, multidrug resistance-associated proteins, and P-glycoprotein (P-gp). Proteins related to drug resistance were overexpressed in multidrug-resistant tumor cells. These proteins depended on energy and play important roles in the emergence of drug resistance. The changes in glutathione and cysteine metabolic pathways showed that the cells can activate related metabolic pathways and reduce the cell apoptosis when they encounter oxidative damage. These findings indicate that drug resistance is likely associated with increased P-gp synthesis and reduced apoptosis of tumor cells. Graphical Abstract Drug resistance was charactered in the changing of genomics and proteomics. Like enhancing DNA repair, reducing uptake, high P-g protein expression. Here, we studied the changes of metabolite pathway which could be also play an imported role in drug resistance.

Entities:  

Keywords:  Cell metabolomics; Multidrug resistance; Tumor; Ultra-performance liquid chromatography–mass spectrometry

Mesh:

Substances:

Year:  2016        PMID: 27379392     DOI: 10.1007/s00216-016-9696-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  5 in total

Review 1.  Experimental design and reporting standards for metabolomics studies of mammalian cell lines.

Authors:  Sarah Hayton; Garth L Maker; Ian Mullaney; Robert D Trengove
Journal:  Cell Mol Life Sci       Date:  2017-07-01       Impact factor: 9.261

2.  A novel method to detect intracellular metabolite alterations in MCF-7 cells by doxorubicin induced cell death.

Authors:  Ajay Kumar; Sheetal Patel; Devyani Bhatkar; Sachin C Sarode; Nilesh Kumar Sharma
Journal:  Metabolomics       Date:  2021-01-03       Impact factor: 4.290

3.  Metabolomics analysis of multidrug-resistant breast cancer cells in vitro using methyl-tert-butyl ether method.

Authors:  Li Zong; Zifeng Pi; Shu Liu; Zhiqiang Liu; Fengrui Song
Journal:  RSC Adv       Date:  2018-04-26       Impact factor: 4.036

Review 4.  Metabolomics study of oral cancers.

Authors:  Xun Chen; Dongsheng Yu
Journal:  Metabolomics       Date:  2019-02-08       Impact factor: 4.290

5.  Metabolomics: a promising diagnostic and therapeutic implement for breast cancer.

Authors:  Zhanghan Chen; Zehuan Li; Haoran Li; Ying Jiang
Journal:  Onco Targets Ther       Date:  2019-08-21       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.